Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads by Date Must reads for theWeek ending May 3, 2020 Cautionary findings on acquired immunodeficiency from anti-CD20 MS therapy, Five-year siponimod data support early MS treatment, Economic burden of migraine increases with the number of treatment failures, Case series suggests biologics, JAK inhibitors safe during pandemic, Antitumor treatment may increase risk of severe events in COVID-19 patients, More must reads Must reads for theWeek ending April 26, 2020 Dermatomyositis without dermatitis correlates with autoantibodies, ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients, Optimal blood pressure to protect cognitive function in elderly populations is unknown, Many nursing home residents with dementia receive questionable medications, Pandemic poses distinct challenges for people with dementia, More must readsMust reads for theWeek ending April 19, 2020 N.Y. universal testing: Many COVID-19+ pregnant women are asymptomatic, Severe COVID-19 may lower hemoglobin levels, Inflammatory markers may explain COVID-19, diabetes dynamic, OSA increases odds of hospital readmission after COPD exacerbation, Klotho allele lowers APOE4-associated risk of Alzheimer’s, More must readsMust reads for theWeek ending April 12, 2020 National Watchman registry reports impressive procedural safety, Treatment for RA, SpA may not affect COVID-19 severity, JAK inhibitors may increase risk of herpes zoster, Cytokine release syndrome in severe COVID-19: Is tocilizumab effective?, Stress and trauma raise risk for neurodegenerative disease, More must readsMust reads for theWeek ending March 29, 2020 Renal denervation shown safe and effective in pivotal trial, Reports suggest possible in utero transmission of novel coronavirus 2019, Targeting gut bacteria may improve levodopa uptake, Sleep-disordered breathing linked with Alzheimer’s disease biomarkers in cognitively normal older adults, Intracranial artery stenting shows promising 1-year results, More must readsPages« first 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 last »